Literature DB >> 35648331

Subclinical cognitive deficits are associated with reduced cerebrovascular response to visual stimulation in mid-sixties men.

Mark Bitsch Vestergaard1, Ulrich Lindberg2, Maria Højberg Knudsen2, Olalla Urdanibia-Centelles3, Aftab Bakhtiari2,3, Erik Lykke Mortensen4, Merete Osler4, Birgitte Fagerlund5,6, Krisztina Benedek3, Martin Lauritzen3,7, Henrik Bo Wiberg Larsson2,7.   

Abstract

Reduced cerebrovascular response to neuronal activation is observed in patients with neurodegenerative disease. In the present study, we examined the correlation between reduced cerebrovascular response to visual activation (ΔCBFVis.Act) and subclinical cognitive deficits in a human population of mid-sixties individuals without neurodegenerative disease. Such a correlation would suggest that impaired cerebrovascular function occurs before overt neurodegenerative disease. A total of 187 subjects (age 64-67 years) of the Metropolit Danish Male Birth Cohort participated in the study. ΔCBFVis.Act was measured using arterial spin labelling (ASL) MRI. ΔCBFVis.Act correlated positively with cognitive performance in: Global cognition (p = 0.046), paired associative memory (p = 0.025), spatial recognition (p = 0.026), planning (p = 0.016), simple processing speed (p < 0.01), and with highly significant correlations with current intelligence (p < 10-5), and more complex processing speed (p < 10-3), the latter two explaining approximately 11-13% of the variance. Reduced ΔCBFVis.Act was independent of brain atrophy. Our findings suggest that inhibited cerebrovascular response to neuronal activation is an early deficit in the ageing brain and associated with subclinical cognitive deficits. Cerebrovascular dysfunction could be an early sign of a trajectory pointing towards the development of neurodegenerative disease. Future efforts should elucidate if maintenance of a healthy cerebrovascular function can protect against the development of dementia.
© 2022. The Author(s).

Entities:  

Keywords:  Brain ageing; Brain physiology; Cerebral perfusion; Cerebrovascular function; Neurovascular coupling

Year:  2022        PMID: 35648331     DOI: 10.1007/s11357-022-00596-2

Source DB:  PubMed          Journal:  Geroscience        ISSN: 2509-2723            Impact factor:   7.713


  48 in total

Review 1.  Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease.

Authors:  Helene Girouard; Costantino Iadecola
Journal:  J Appl Physiol (1985)       Date:  2006-01

2.  Perfusion fMRI detects deficits in regional CBF during memory-encoding tasks in MCI subjects.

Authors:  G Xu; P G Antuono; J Jones; Y Xu; G Wu; D Ward; S-J Li
Journal:  Neurology       Date:  2007-10-23       Impact factor: 9.910

Review 3.  Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests.

Authors:  K A Bates; G Verdile; Q-X Li; D Ames; P Hudson; C L Masters; R N Martins
Journal:  Mol Psychiatry       Date:  2008-09-16       Impact factor: 15.992

Review 4.  Cerebrovascular reactivity to carbon dioxide in Alzheimer's disease.

Authors:  Lidia Glodzik; Catherine Randall; Henry Rusinek; Mony J de Leon
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

5.  Cerebrovascular reactivity and cognitive decline in patients with Alzheimer disease.

Authors:  Mauro Silvestrini; Patrizio Pasqualetti; Roberto Baruffaldi; Marco Bartolini; Yasmin Handouk; Maria Matteis; Filomena Moffa; Leandro Provinciali; Fabrizio Vernieri
Journal:  Stroke       Date:  2006-02-23       Impact factor: 7.914

6.  Increasing required neural response to expose abnormal brain function in mild versus moderate or severe Alzheimer's disease: PET study using parametric visual stimulation.

Authors:  M J Mentis; G E Alexander; J Krasuski; P Pietrini; M L Furey; M B Schapiro; S I Rapoport
Journal:  Am J Psychiatry       Date:  1998-06       Impact factor: 18.112

Review 7.  Brain imaging of neurovascular dysfunction in Alzheimer's disease.

Authors:  Axel Montagne; Daniel A Nation; Judy Pa; Melanie D Sweeney; Arthur W Toga; Berislav V Zlokovic
Journal:  Acta Neuropathol       Date:  2016-04-01       Impact factor: 17.088

8.  Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre.

Authors:  Jon B Toledo; Steven E Arnold; Kevin Raible; Johannes Brettschneider; Sharon X Xie; Murray Grossman; Sarah E Monsell; Walter A Kukull; John Q Trojanowski
Journal:  Brain       Date:  2013-07-10       Impact factor: 13.501

Review 9.  Glial and neuronal control of brain blood flow.

Authors:  David Attwell; Alastair M Buchan; Serge Charpak; Martin Lauritzen; Brian A Macvicar; Eric A Newman
Journal:  Nature       Date:  2010-11-11       Impact factor: 49.962

10.  A brain stress test: Cerebral perfusion during memory encoding in mild cognitive impairment.

Authors:  Long Xie; Sudipto Dolui; Sandhitsu R Das; Grace E Stockbower; Molly Daffner; Hengyi Rao; Paul A Yushkevich; John A Detre; David A Wolk
Journal:  Neuroimage Clin       Date:  2016-03-02       Impact factor: 4.881

View more
  1 in total

1.  New hallmarks of ageing: a 2022 Copenhagen ageing meeting summary.

Authors:  Tomas Schmauck-Medina; Adrian Molière; Sofie Lautrup; Jianying Zhang; Stefan Chlopicki; Helena Borland Madsen; Shuqin Cao; Casper Soendenbroe; Els Mansell; Mark Bitsch Vestergaard; Zhiquan Li; Yosef Shiloh; Patricia L Opresko; Jean-Marc Egly; Thomas Kirkwood; Eric Verdin; Vilhelm A Bohr; Lynne S Cox; Tinna Stevnsner; Lene Juel Rasmussen; Evandro F Fang
Journal:  Aging (Albany NY)       Date:  2022-08-29       Impact factor: 5.955

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.